| Literature DB >> 35154530 |
Łukasz Wierucki1, Hanna Kujawska-Danecka2, Małgorzata Mossakowska3, Tomasz Grodzicki4, Piotr Błędowski5, Jerzy Chudek6, Tomasz Kostka7, Andrzej Więcek8, Adam Hajduk2, Piotr Bandosz1, Paweł Zagożdżon9, Bogdan Wojtyniak10, Tomasz Zdrojewski1.
Abstract
INTRODUCTION: Population ageing constitutes an increasing medical, social, and economic burden worldwide. Optimal senior policy should be based on well-assessed knowledge on the prevalence and control of age-related diseases, multimorbidity, disabilities, and their social determinants. The objective of this paper is to describe the assumptions, methods, and sampling procedures of the PolSenior2 survey, which was aimed at characterising the health status of old and very-old adults in Poland.Entities:
Keywords: PolSenior2; ageing; cross-sectional survey; national; older population health
Year: 2020 PMID: 35154530 PMCID: PMC8826695 DOI: 10.5114/aoms.2020.100898
Source DB: PubMed Journal: Arch Med Sci ISSN: 1734-1922 Impact factor: 3.318
Figure 1The PolSenior2 study flowchart
Blood and urine parameters analysed in the study including methods of assessment
| Parameter | Biologic material | Method of assessment | Assay kit catalogue number | Accuracy (%) |
|---|---|---|---|---|
| Complete blood count | Blood | Various automated haematology analysers | n/a | n/a |
| Glycated haemoglobin | Blood | HPLC | 2702455EX | 0.24 |
| Fasting glucose | Fluoride plasma | Enzymatic (hexokinase) | 11097592 | 1.1 |
| Intact parathyroid hormone | EDTA plasma | Chemiluminescent immunoassay | 10995621 | 3.4 |
| Total cholesterol | Serum | Enzymatic (cholesterol esterase) | 11097609 | 1.3 |
| LDL-cholesterol | Serum | Enzymatic (cholesterol oxidase) | 11097632 | 1.6 |
| HDL-cholesterol | Serum | Enzymatic (cholesterol esterase) | 11097630 | 1.6 |
| Triglycerides | Serum | Enzymatic (glycerol phosphate oxidase) | 11097591 | 2.5 |
| Creatinine | Serum | Enzymatic (creatinine hydrolase) | 11097533 | 2.5 |
| Uric acid | Serum | Enzymatic (uricase) | 11097608 | 1.5 |
| Bilirubin | Serum | Spectrophotometric | 11097531 | 6.3 |
| Alanine transaminase | Serum | Spectrophotometric | 11097605 | 2.8 |
| Aspartate transaminase | Serum | Spectrophotometric | 11097607 | 1.7 |
| γ-glutamyl transferase | Serum | Spectrophotometric | 11097597 | 1.5 |
| Alkaline phosphatase | Serum | Spectrophotometric | 11097600 | 1.3 |
| Phosphates | Serum | Spectrophotometric | 11097611 | 4.6 |
| Total calcium | Serum | Spectrophotometric | 11097644 | 1.5 |
| Iron | Serum | Spectrophotometric | 11097601 | 2.6 |
| Albumin | Serum | Spectrophotometric | 11097590 | 2.4 |
| Transferrin | Serum | Immunoturbidimetric | 11097613 | 1.9 |
| C-reactive protein | Serum | Immunoturbidimetric (high sensitivity) | 11097633 | 7.4 |
| Cystatin C | Serum | Nephelometric | OQNM17 | 4.3 |
| 25-hydroksy vitamin D | Serum | Chemiluminescent immunoassay | 10995719 | 8.0 |
| Vitamin B12 | Serum | Chemiluminescent immunoassay | 10995714 | 6.4 |
| Folic acid | Serum | Chemiluminescent immunoassay | 10995572 | 7.1 |
| Insulin | Serum | Chemiluminescent immunoassay | 10995628 | 3.6 |
| C-peptide | Serum | Chemiluminescent immunoassay | 10995541 | 4.9 |
| Thyroid-stimulating hormone | Serum | Chemiluminescent immunoassay | 10995703 | 3.7 |
| Anti-thyroid peroxidase antibodies | Serum | Chemiluminescent immunoassay | 10995466 | 7.4 |
| Total prostate specific antigen | Serum | Chemiluminescent immunoassay | 10995662 | 8.5 |
| HBs antigen | Serum | Chemiluminescent immunoassay | 10995604 | 7.5 |
| anti-HBs antibodies | Serum | Chemiluminescent immunoassay | 10995453 | 5.3 |
| Anti-HBc antibodies | Serum | Chemiluminescent immunoassay | 10995597 | 9.5 |
| Anti-HCV antibodies | Serum | Chemiluminescent immunoassay | 10995456 | 11.5 |
| Albumin | Urine | Immunoturbidimetric | 11097610 | 3.6 |
| Creatinine | Urine | Enzymatic (creatinine hydrolase) | 11097533 | 3.2 |
HbA1c assays were made on Biorad kits, all others blood and urine analysis were performed using Siemens Healthcare kits
in subject with eGFR < 60 ml/min/1.73 m2
only in men.
Sociodemographic characteristics of PolSenior2 study group
| Parameter | Women ( | Men ( | Total ( |
|---|---|---|---|
| Age cohorts [years]: | |||
| 60–64 | 493 (16.1%) | 437 (14.9%) | 930 (15.5%) |
| 65–69 | 594 (19.4%) | 525 (17.9%) | 1119 (18.7%) |
| 70–74 | 512 (16.7%) | 540 (18.4%) | 1052 (17.6%) |
| 75–79 | 455 (14.9%) | 455 (15.5%) | 910 (15.2%) |
| 80–84 | 437 (14.3%) | 409 (14.0%) | 846 (14.1%) |
| 85–89 | 320 (10.5%) | 294 (10.0%) | 614 (10.3%) |
| ≥ 90 | 246 (8.0%) | 270 (9.2%) | 516 (8.6%) |
| Education: | |||
| No education | 58 (1.9%) | 20 (0.7%) | 78 (1.3%) |
| Primary (incomplete) | 79 (2.6%) | 43 (1.5%) | 122 (2.0%) |
| Primary | 869 (28.4%) | 642 (21.9%) | 1511 (25.2%) |
| Middle: gymnasium | 12 (0.4%) | 5 (0.2%) | 17 (0.3%) |
| Middle: vocational school | 557 (18.2%) | 880 (30.0%) | 1437 (24.0%) |
| Secondary | 911 (29.8%) | 774 (26.4%) | 1685 (28.1%) |
| Post–secondary | 154 (5.1%) | 78 (2.6%) | 232 (3.9%) |
| Tertiary: bachelor’s, engineer’s degree | 116 (3.8%) | 222 (7.6%) | 338 (5.7%) |
| Tertiary: master’s degree | 236 (7.7%) | 210 (7.2%) | 446 (7.5%) |
| No data | 65 (2.1%) | 56 (1.9%) | 121 (2.0%) |
| Place of residence: | |||
| Village | 1083 (35.4%) | 1022 (34.9%) | 2105 (35.2%) |
| City < 50 thou. | 781 (25.5%) | 720 (24.6%) | 1501 (25.1%) |
| City 50–200 thou. | 559 (18.3%) | 596 (20.3%) | 1155 (19.3%) |
| City > 200 thou. | 634 (20.7%) | 592 (20.2%) | 1226 (20.5%) |
| Macroregions: | |||
| Południowy | 611 (20.0%) | 643 (21.9%) | 1254 (20.9%) |
| Północno-zachodni | 445 (14.6%) | 451 (15.4%) | 896 (15.0%) |
| Południowo-zachodni | 364 (11.9%) | 314 (10.7%) | 678 (11.3%) |
| Północny | 453 (14.8%) | 413 (14.1%) | 866 (14.5%) |
| Centralny | 302 (9.9%) | 292 (10.0%) | 594 (9.9%) |
| Wschodni | 441 (14.4%) | 430 (14.7%) | 871 (14.5%) |
| Województwo mazowieckie | 441 (14.4%) | 387 (13.2%) | 828 (13.8%) |
| Marital status: | |||
| Single | 99 (3.2%) | 80 (2.7%) | 179 (3.0%) |
| Divorced or separated | 142 (4.7%) | 84 (2.9%) | 226 (3.8%) |
| Widowed | 1420 (46.5%) | 480 (16.4%) | 1900 (31.7%) |
| Married | 1309 (42.8%) | 2206 (75.3%) | 3515 (58.7%) |
| No data | 87 (2.8%) | 80 (2.7%) | 167 (2.8%) |
| Living arrangements: | |||
| Alone | 848 (29.2%) | 365 (13.0%) | 1213 (21.3%) |
| With spouse | 1271 (43.9%) | 2169 (77.7%) | 3440 (60.5%) |
| With children, grandchildren, great–grandchildren | 1140 (39.5%) | 894 (32.1%) | 2034 (35.9%) |
| With other family members | 105 (3.7%) | 130 (4.7%) | 235 (4.2%) |
| No data | 153 (5.0%) | 132 (4.5%) | 285 (4.8%) |